Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 14, 2021 and accepted by EDGAR at May 14, 2021, 20:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$18.2kus-gaap:Revenues
Revenue6 months2020-10-01 to 2021-03-31$89.7kus-gaap:Revenues
Cost of revenue3 months2021-01-01 to 2021-03-31$39.4kus-gaap:CostOfRevenue
Cost of revenue6 months2020-10-01 to 2021-03-31$148.5kus-gaap:CostOfRevenue
Gross profit3 months2021-01-01 to 2021-03-31−$21.1kus-gaap:GrossProfit
Gross profit6 months2020-10-01 to 2021-03-31−$58.8kus-gaap:GrossProfit
Research and development3 months2021-01-01 to 2021-03-31$1.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-10-01 to 2021-03-31$2.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-01-01 to 2021-03-31−$2.4mus-gaap:OperatingIncomeLoss
Operating income6 months2020-10-01 to 2021-03-31−$4.5mus-gaap:OperatingIncomeLoss
Net income3 months2021-01-01 to 2021-03-31−$2.4mus-gaap:NetIncomeLoss
Net income6 months2020-10-01 to 2021-03-31−$4.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31−$0.21us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2020-10-01 to 2021-03-31−$0.46us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2020-10-01 to 2021-03-31−$4.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2021-03-31$11.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$11.4mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$11.9mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$750.4kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$1.1mus-gaap:Liabilities
Shareholders' equityAt period end2021-03-31$10.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-21-026426. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.